Celgene is in the business to make money and if MMRF's bio assets had not contributed to the advancement of a new money making drug then MMRF's milestone payments would be terminated! Evidently FDA verifys continued process of Celgenes endeavor to perfect this new cancer drug. If this drug hits the worldwide market, then I believe MMRF will receive a hugh initial payment and royalties thereafter! Celgene currently thinks so and so do I.....JMO....Tiffer
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.